A Look At The Test That Allows Scientists To Detect Extremely Rare Cancer Cells In Blood
San Diego’s Epic Sciences' technology is part of the field known as “liquid biopsies,” which uses blood to detect diseases, mainly cancers, and evaluate how they respond to treatment.
San Diego Union-Tribune:
An Epic Quest To Detect Cancer
Finding needles in a haystack is the life-and-death job of San Diego’s Epic Sciences. The needles are extremely rare cancer cells that hide among the millions of normal cells in the blood of cancer patients. The privately held company uses a combination of imaging technology to detect abnormal cells in a blood sample, along with DNA sequencing of those abnormal cells for cancer. A spinoff of The Scripps Research Institute, Epic Sciences raised $40 million in venture funding in May to further develop its technology. (Fikes, 12/6)